Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/1996
05/30/1996WO1996015808A1 Method for making a medicament for treating secondary immunodeficiency
05/30/1996WO1996015800A1 Method for treating secondary immunodeficiency
05/30/1996WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
05/30/1996WO1996015669A1 Prophylactic treatment of allergic contact dermatitis
05/30/1996DE19541284A1 Verfahren zur Immunmodulation Methods for immunomodulation
05/30/1996CA2205920A1 Prophylactic treatment of allergic contact dermatitis
05/30/1996CA2205532A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
05/30/1996CA2204147A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
05/29/1996EP0713704A1 2-Amino-1,3-thiazines as nitric oxide synthase inhibitors
05/29/1996EP0713698A2 Medical use of atypical beta-adrenoceptor agonists
05/29/1996EP0713483A1 Amidine derivatives with nitric oxide synthetase activities
05/29/1996EP0469065B1 Recombinant antibody-toxin fusion protein
05/28/1996US5521315 Olefin substituted long chain compounds
05/28/1996US5521220 Treating inflammatory and central nervous system disorders
05/28/1996US5521198 Methods of inhibiting autoimmune diseases
05/28/1996US5521194 Antiproliferative agent for restenosis treatment
05/28/1996US5521187 Phosphodiesterase inhibitors, antiallergens and atopic diseases
05/28/1996US5521185 Methods for inhibiting graft rejection and IL-1 production
05/28/1996CA1338352C 2-substituted quinolines
05/26/1996CA2163724A1 2-amino-1,3-thiazines as inhibitors of nitric oxide synthase
05/23/1996WO1996015249A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996WO1996015238A1 Targeted t lymphocytes
05/23/1996WO1996015234A2 Lipid-splitting enzyme
05/23/1996WO1996015153A1 Human antibodies to t-cell receptor peptides and methods for their preparation
05/23/1996WO1996015146A1 Conjugates of bdnf and nt-3 with a water-soluble polymer
05/23/1996WO1996015131A1 Macrocyclic lactone compounds and their production process
05/23/1996WO1996014876A1 Yeast-based delivery vehicles
05/23/1996WO1996014874A1 Method for gene therapy involving suppression of an immune response
05/23/1996WO1996014844A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase
05/23/1996CA2205138A1 Human antibodies to t-cell receptor peptides and methods for their preparation
05/23/1996CA2204914A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996CA2204908A1 Lipid cleavage enzyme
05/23/1996CA2203934A1 Targeted t lymphocytes
05/22/1996EP0712936A1 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
05/22/1996EP0712926A2 Fish pancreatic disease virus
05/22/1996EP0712631A2 Cyclosporin containing multiple emulsions
05/22/1996EP0712402A1 Hydroisoquinoline derivatives
05/22/1996EP0712277A1 Jak kinases and regulation of cytokine signal transduction
05/22/1996EP0637299B1 20-methyl-substituted vitamin d derivates
05/22/1996CN1122715A Functional oral liquor for enhancing human immunity
05/22/1996CN1122693A Medical use of RNA from poultry embryo
05/21/1996US5519117 Polypeptide sequences as anticarcinogenic agents
05/21/1996US5519042 Method of treating hyperproliferative vascular disease
05/21/1996US5519028 Antiviral preparations
05/21/1996US5519022 α, α dialkylbenzyl derivatives
05/21/1996US5519018 Substituted phenols and their use for the treatment of disorders caused by cell proliferation
05/21/1996US5519005 Guanidine terminated peptides for treatment of thrombosis, antitumor agents, autoimmune diseases and immunology
05/21/1996US5518911 Human PAK65
05/21/1996US5518725 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
05/21/1996CA2043860C Pyrrolo-pyridine derivatives, a process for their preparation and therapeutic compositions containing them
05/21/1996CA2017573C 4-(hydroxydiphenylmethyl)-1-piperidylphenylalkane derivatives as antihistamines and a method of treatment of an allergic response
05/18/1996CA2160841A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
05/17/1996WO1996014407A1 Recombinant alternaria alternata allergens
05/17/1996WO1996014401A1 Transgenic organisms and their uses
05/17/1996WO1996014394A1 Human dna ligase iii
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014333A1 Peptides for anti-allergy treatment
05/17/1996WO1996014317A1 Novel piperidine derivatives with paf antagonist activity
05/17/1996WO1996014302A1 Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
05/17/1996WO1996014079A1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
05/17/1996WO1996014078A1 Extract of crataegus, process for producing it and its use
05/17/1996WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
05/17/1996WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
05/17/1996WO1996004266A3 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
05/17/1996CA2689871A1 Combined meningitis vaccine
05/17/1996CA2204362A1 Recombinant alternaria alternata allergens
05/17/1996CA2204256A1 Peptides for anti-allergy treatment
05/17/1996CA2203935A1 Transgenic organisms and their uses
05/17/1996CA2203368A1 Extract of crataegus, process for producing it and its use
05/15/1996EP0711829A2 Recombinant alphavirus vectors
05/15/1996EP0711765A1 Immunosuppressive cyclolignan derivatives
05/15/1996EP0711550A1 Cyclosporin-containing soft capsule compositions
05/15/1996EP0711345A1 B7-2: ctl a4/cd 28 counter receptor
05/15/1996EP0711305A1 Protegrins
05/15/1996EP0711298A1 Activated macrolactams having immunomodulatory activities
05/15/1996EP0711297A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0711280A1 Perhydroisoindole derivatives as p substance antagonists
05/15/1996EP0711168A1 Methods of treating apoptosis and associated conditions
05/15/1996EP0711160A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes
05/15/1996EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
05/15/1996EP0465565B1 Treatment of aids dementia, myelopathy and blindness
05/15/1996EP0343217B1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
05/15/1996CN1122600A Second messenger cell signaling inhibitors
05/15/1996CN1122571A High dose formulations
05/15/1996CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid
05/15/1996CN1122329A Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
05/15/1996CN1122247A Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment
05/15/1996CN1122239A Ant composite and its preparation
05/15/1996CN1122236A Medicine for treating AIDS and its preparing method
05/15/1996CA2162760A1 Immunosuppressive cyclolignan derivatives
05/14/1996US5516908 1,3-dihydro-2H-imidazo-[4,5-β]quinolin-2-one derivatives and intermediates
05/14/1996US5516797 Suppressing graft rejection
05/14/1996US5516784 Anti-HIV (AIDS) agents
05/14/1996US5516764 Anti-inflammatory agent
05/14/1996CA2008632C Method of inducing the production of cytokines
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013599A1 Nucleic acid transfer system
05/09/1996WO1996013590A2 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
1 ... 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 ... 1172